Skip to Main Content

Author Details

David Sachs
Icahn School of Medicine at Mount Sinai
2013
29
21
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35325615PPARdelta activation induces metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes.Cell Stem Cell2022
35325615PPARdelta activation induces metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes.Cell Stem Cell2022
33577760Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.Immunity2021
33577760Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.Immunity2021
32416070Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.Cell2020
32416070Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.Cell2020
33035269Genome-wide transposon mutagenesis of paramyxoviruses reveals constraints on genomic plasticity.PLoS Pathog2020
33035269Genome-wide transposon mutagenesis of paramyxoviruses reveals constraints on genomic plasticity.PLoS Pathog2020
31557312Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic coculture.FEBS Lett2019
31851929Viral Fitness Landscapes in Diverse Host Species Reveal Multiple Evolutionary Lines for the NS1 Gene of Influenza A Viruses.Cell Rep2019
31557312Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic coculture.FEBS Lett2019
31851929Viral Fitness Landscapes in Diverse Host Species Reveal Multiple Evolutionary Lines for the NS1 Gene of Influenza A Viruses.Cell Rep2019
29339472miRNA-mediated targeting of human cytomegalovirus reveals biological host and viral targets of IE2.Proc Natl Acad Sci U S A2018
29339472miRNA-mediated targeting of human cytomegalovirus reveals biological host and viral targets of IE2.Proc Natl Acad Sci U S A2018
28658212RNase III nucleases from diverse kingdoms serve as antiviral effectors.Nature2017
28469811Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection.World J Hepatol2017
28642329Experimental and Computational Insight Into Human Mesenchymal Stem Cell Paracrine Signaling and Heterocellular Coupling Effects on Cardiac Contractility and Arrhythmogenicity.Circ Res2017
28813663A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor.Cell Rep2017
28658212RNase III nucleases from diverse kingdoms serve as antiviral effectors.Nature2017
28515302Transposon Mutagenesis of the Zika Virus Genome Highlights Regions Essential for RNA Replication and Restricted for Immune Evasion.J Virol2017
28469811Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection.World J Hepatol2017
28813663A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor.Cell Rep2017
28515302Transposon Mutagenesis of the Zika Virus Genome Highlights Regions Essential for RNA Replication and Restricted for Immune Evasion.J Virol2017
28642329Experimental and Computational Insight Into Human Mesenchymal Stem Cell Paracrine Signaling and Heterocellular Coupling Effects on Cardiac Contractility and Arrhythmogenicity.Circ Res2017
27001854Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity.Proc Natl Acad Sci U S A2016
27142077Differences in Early Cytokine Production Are Associated With Development of a Greater Number of Symptoms Following West Nile Virus Infection.J Infect Dis2016
26789921Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection.Immunity2016
27001854Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity.Proc Natl Acad Sci U S A2016
27142077Differences in Early Cytokine Production Are Associated With Development of a Greater Number of Symptoms Following West Nile Virus Infection.J Infect Dis2016
26789921Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection.Immunity2016
25163420Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model.Mol Imaging Biol2015
26651947microRNA Function Is Limited to Cytokine Control in the Acute Response to Virus Infection.Cell Host Microbe2015
26004185Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins.Cell Rep2015
26549455Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon Response.Cell Rep2015
26074083In Vivo RNAi Screening Identifies MDA5 as a Significant Contributor to the Cellular Defense against Influenza A Virus.Cell Rep2015
25163420Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model.Mol Imaging Biol2015
26651947microRNA Function Is Limited to Cytokine Control in the Acute Response to Virus Infection.Cell Host Microbe2015
26549455Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon Response.Cell Rep2015
26074083In Vivo RNAi Screening Identifies MDA5 as a Significant Contributor to the Cellular Defense against Influenza A Virus.Cell Rep2015
26004185Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins.Cell Rep2015
24275658Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virus.J Biol Chem2014
25456074Influenza A virus transmission bottlenecks are defined by infection route and recipient host.Cell Host Microbe2014
24275658Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virus.J Biol Chem2014
24953656The Mammalian response to virus infection is independent of small RNA silencing.Cell Rep2014
25135297Long-term survival of influenza virus infected club cells drives immunopathology.J Exp Med2014
25065814Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response.Hepatology2014
24778219Drosha as an interferon-independent antiviral factor.Proc Natl Acad Sci U S A2014
25456074Influenza A virus transmission bottlenecks are defined by infection route and recipient host.Cell Host Microbe2014
25065814Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response.Hepatology2014
25135297Long-term survival of influenza virus infected club cells drives immunopathology.J Exp Med2014
  • 1 - 50 of 58

Recommended Authors

Yushen Du
University of California los angeles
Career Start Year 2014
Number of shared co-authors 2
Andreas S Puschnik
Stanford University School of Medicine
Career Start Year 2013
Number of shared co-authors 2
Jessica Sook Yuin Ho
Icahn School of Medicine at Mount Sinai, Duke-NUS Medical School
Career Start Year 2012
Number of shared co-authors 20
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 2
Siyuan Ding
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 3
Colm Atkins
Rutgers University
Career Start Year 2007
Number of shared co-authors 3
Amie J Eisfeld
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 2006
Number of shared co-authors 1
Richard Green
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2005
Number of shared co-authors 1
Jean Chang
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2005
Number of shared co-authors 0
Jan Rehwinkel
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 2004
Number of shared co-authors 1
Yaw Shin Ooi
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 1
Balaji Manicassamy
University of Iowa
Career Start Year 2002
Number of shared co-authors 14
Sumit K Chanda
The Scripps Research Institute
Career Start Year 2001
Number of shared co-authors 22
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 16
Sean C Proll
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 3
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
Victor R DeFilippis
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 0
Renate K??nig
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 11
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 6
Renee C Ireton
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1997
Number of shared co-authors 1
Abraham L Brass
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 5
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 13
Melanie Ott
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 8
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 3
Ren Sun
University of California los angeles
Career Start Year 1992
Number of shared co-authors 5
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 2
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1988
Number of shared co-authors 2
Michael G Katze
University of Washington
Career Start Year 1978
Number of shared co-authors 4

Collaborators

Benjamin R tenOever
NYU Grossman School of Medicine
Co-authored papers 14
Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Jean K Lim
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Nicholas S Heaton
Duke University School of Medicine
Co-authored papers 6
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Michael D Linderman
Middlebury College
Co-authored papers 2
Domenico Tortorella
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Joshua Mayourian
Co-authored papers 2
Rong Hai
University of California riverside
Co-authored papers 2
Eric A Sobie
Co-authored papers 2
Sara Cherry
University of Pennsylvania
Co-authored papers 2
Benhur Lee
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Jennifer R Hamilton
University of California berkeley
Co-authored papers 2
Benjamin K Chen
Co-authored papers 1
Carlos-Filipe Pereira
Co-authored papers 1
Rafael Dariolli
Co-authored papers 1
Madhavika N Serasinghe
Co-authored papers 1
Kateri A Moore
Co-authored papers 1
Laura Campisi
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Benjamin D Greenbaum
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Vinod R M T Balasubramaniam
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia
Co-authored papers 1
Namita Satija
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Natasha Moshkina
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Jeffrey M Bernitz
Co-authored papers 1
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Toni M Schwarz
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Nadeera M Wickramasinghe
Co-authored papers 1
Release 1.2